These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

299 related articles for article (PubMed ID: 31651200)

  • 81. The Role of Circulating Tumor DNA in Renal Cell Carcinoma.
    Bergerot PG; Hahn AW; Bergerot CD; Jones J; Pal SK
    Curr Treat Options Oncol; 2018 Feb; 19(2):10. PubMed ID: 29464405
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Computational Analysis of DNA and RNA Sequencing Data Obtained from Liquid Biopsies.
    Marass F; Castro-Giner F; Szczerba BM; Jahn K; Kuipers J; Aceto N; Beerenwinkel N
    Recent Results Cancer Res; 2020; 215():347-368. PubMed ID: 31605238
    [TBL] [Abstract][Full Text] [Related]  

  • 83. The Elusive Horizon: Biomarkers in Urothelial Carcinoma.
    Linscott JA; Meeks JJ; Dyrskjøt L; Li R
    Eur Urol; 2024 Apr; 85(4):317-319. PubMed ID: 38278663
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Liquid biopsy for the detection of clinical biomarkers in early breast cancer: new insights and challenges.
    Matsutani A; Udagawa C; Matsunaga Y; Nakamura S; Zembutsu H
    Pharmacogenomics; 2020 Apr; 21(5):359-367. PubMed ID: 32284011
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Toward liquid biopsies in cancer treatment: application of circulating tumor DNA.
    Barlebo Ahlborn L; Østrup O
    APMIS; 2019 May; 127(5):329-336. PubMed ID: 30784124
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Cell-Free Circulating DNA Integrity Based on Peripheral Blood as a Biomarker for Diagnosis of Cancer: A Systematic Review.
    Cheng J; Tang Q; Cao X; Burwinkel B
    Cancer Epidemiol Biomarkers Prev; 2017 Nov; 26(11):1595-1602. PubMed ID: 28830871
    [No Abstract]   [Full Text] [Related]  

  • 87. Role of circulating tumor DNA in the management of patients with colorectal cancer.
    Moati E; Taly V; Didelot A; Perkins G; Blons H; Taieb J; Laurent-Puig P; Zaanan A
    Clin Res Hepatol Gastroenterol; 2018 Oct; 42(5):396-402. PubMed ID: 29627453
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Bladder cancer: The promise of liquid biopsy ctDNA analysis.
    Thoma C
    Nat Rev Urol; 2017 Oct; 14(10):580-581. PubMed ID: 28813035
    [No Abstract]   [Full Text] [Related]  

  • 89. Genetic profiling of cancer with circulating tumor DNA analysis.
    Lu L; Bi J; Bao L
    J Genet Genomics; 2018 Feb; 45(2):79-85. PubMed ID: 29502957
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Liquid biopsy: an evolving paradigm for the biological characterisation of plasma cell disorders.
    Mithraprabhu S; Chen M; Savvidou I; Reale A; Spencer A
    Leukemia; 2021 Oct; 35(10):2771-2783. PubMed ID: 34262132
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Utilizing circulating tumour DNA in radiation oncology.
    Rostami A; Bratman SV
    Radiother Oncol; 2017 Sep; 124(3):357-364. PubMed ID: 28735685
    [TBL] [Abstract][Full Text] [Related]  

  • 92. A fluid solution: Scientists explore use of liquid biopsy tests to find cancer DNA.
    Printz C
    Cancer; 2018 May; 124(9):1853-1854. PubMed ID: 29676792
    [No Abstract]   [Full Text] [Related]  

  • 93. Diagnostic Power of DNA Methylation Classifiers for Early Detection of Cancer.
    Roy D; Tiirikainen M
    Trends Cancer; 2020 Feb; 6(2):78-81. PubMed ID: 32061307
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Tumor-specific genetic aberrations in cell-free DNA of gastroesophageal cancer patients.
    Koldby KM; Mortensen MB; Detlefsen S; Pfeiffer P; Thomassen M; Kruse TA
    J Gastroenterol; 2019 Feb; 54(2):108-121. PubMed ID: 30242476
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Technical considerations for circulating tumor DNA detection in oncology.
    Franczak C; Filhine-Tresarrieu P; Gilson P; Merlin JL; Au L; Harlé A
    Expert Rev Mol Diagn; 2019 Feb; 19(2):121-135. PubMed ID: 30648442
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Urinary Cell-Free DNA in Liquid Biopsy and Cancer Management.
    Salfer B; Li F; Wong DTW; Zhang L
    Clin Chem; 2022 Dec; 68(12):1493-1501. PubMed ID: 36213956
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Implementing circulating tumor DNA analysis in a clinical laboratory: A user manual.
    Koessler T; Addeo A; Nouspikel T
    Adv Clin Chem; 2019; 89():131-188. PubMed ID: 30797468
    [TBL] [Abstract][Full Text] [Related]  

  • 98. The role of circulating free DNA in the management of NSCLC.
    Esposito Abate R; Pasquale R; Fenizia F; Rachiglio AM; Roma C; Bergantino F; Forgione L; Lambiase M; Sacco A; Piccirillo MC; Morabito A; Normanno N
    Expert Rev Anticancer Ther; 2019 Jan; 19(1):19-28. PubMed ID: 30462523
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Grail to pour $1 billion into blood test to detect early cancer.
    Sheridan C
    Nat Biotechnol; 2017 Feb; 35(2):101-102. PubMed ID: 28178244
    [No Abstract]   [Full Text] [Related]  

  • 100. Are liquid biopsies ready for primetime?
    Emamekhoo H; Lang JM
    Cancer; 2019 Mar; 125(6):834-837. PubMed ID: 30582152
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.